4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000118
EVP Chief Patient & Ext Af Off sold 1,846 shares at $486.35 ($897,802)
- EVP Chief Patient & Ext Af Off gave up 1,518 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sachdev Amit · EVP Chief Patient & Ext Af Off
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −1,518 | $485.11 | $736,397 | 57,416 | D |
| 2026-02-25 | Sale : show line 2 in the form 10b5-1 | −1,846 | $486.35 | $897,802 | 55,570 | D |
| Open-market sales · 1,846 sh · avg $486.35 · $897,802 | ||||||
Loading xslF345X05/wk-form4_1772149844.xml…